We investigated the specificity of superparamagnetic iron oxide (SPIO)-enhanced T1-weighted spin-echo (SE) magnetic resonance (MR) images for the characterization of liver hemangiomas. When imaging liver hemangiomas, which are the most frequent benign liver tumors, a method with very high specificity is required, which will obviate other studies, follow-up, or invasive diagnostic procedures such as percutaneous biopsy. Eighty-three lesions were examined by MR imaging at 1.5 T before and after intravenous injection of SPIO particles. Lesions were categorized as follows according to the final diagnosis: 37 hemangiomas, nine focal nodular hyperplasias (FNHs), 19 hepatocellular carcinomas (HCCs), and 18 metastases. Their signal intensity values were normalized to muscle and compared. The only lesions showing a significant increase in signal intensity ratio (lesion to muscle) on postcontrast T1-weighted SE images were hemangiomas (p Ͻ 0.001). The signal intensity ratio of hemangiomas increased on average by 70%. Based on receiver operating characteristic analysis and using a cutoff level of 50% signal increase, the specificity and sensitivity of SPIO-enhanced MR imaging for the characterization of hemangiomas would be 100% and 70%, respectively. The T1 effect of SPIO particles can help differentiate hemangiomas from other focal liver lesions such as FNHs, HCCs, and metastases and may obviate biopsy. When using SPIO particles for liver imaging, it is useful to add a T1-weighted sequence to T2-weighted images, thereby providing additional information for lesion characterization.
Hemangiomas are the most common benign liver tumor and, in the vast majority of cases, do not require surgical treatment [1] . It is therefore important that an imaging-based diagnosis can be made with high specificity to avoid unnecessary complementary examinations or invasive procedures such as percutaneous biopsy or even surgery.
When using ultrasound (US), typical hemangiomas appear as sharply delineated, hyperechoic lesions [2, 3] . In such cases, the diagnosis is easily made. It is more difficult in atypical hemangiomas or when there is a fatty liver, in which hemangiomas are frequently seen as iso-or even hypoechoic lesions [4] . US thus lacks characteristic features, and differentiating hemangiomas from other lesions, such as liver metastases, can be unreliable. Computed tomography (CT) has a good sensitivity for the diagnosis of hemangiomas [5, 6] . However, hemangiomas may have atypical features, for example, intense homogeneous arterial enhancement and early fading [7] . Hemangiomas larger than 3 cm in diameter or smaller than 1 cm rarely show typical enhancement [8] . Moreover, in oncologic patients, characterization of liver nodules is much more critical. Thus, whereas in the general population the diagnosis of hemangioma is made accurately in 76% of cases, this percentage falls to 48% in patients with cancer [9] .
Magnetic resonance imaging (MRI) has been proposed by many investigators [5] for the characterization of hemangiomas. MRI is quite sensitive for the detection of hemangiomas. A T2-weighted sequence is mandatory for the characterization of liver hemangiomas. Moreover, the heavier the T2 weighting of the sequence, the more reliable the differential diagnosis [10, 11] . The adjunction of a dynamic gadolinium chelate-enhanced T1-weighted sequence increases the accuracy of the diagnosis of liver hemangiomas as compared with native T2-weighted images alone [12] . Nevertheless, the diagnostic accuracy of MRI for the characterization of liver hemangiomas has limitations. Shimizu et al. reported cases in which benign lesions were operated because of a diagnosis of malignancy [13] . On the one hand, in most of the patients, the lesions misinterpreted as malignant were hemangiomas and focal nodular hyperplasia (FNH). On the other hand, to call benign a malignant lesion can have deleterious consequences [14] .
In this retrospective study, we evaluated the usefulness of superparamagnetic iron oxide (SPIO) particles for the characterization of hemangiomas. Several studies have demonstrated that SPIO particles improve detection of hepatocellular carcinoma (HCC) [15, 16] or metastasis by using their ability to be phagocytosed by Kupffer cells and to be clustered within them. In this situation, the r2 relaxivity of SPIO particles is very high, which leads to a decrease of T2* of liver parenchyma. However, one also can take advantage of their r1 relaxivity. As with other MRI contrast agents, the T1 effect of SPIO particles predominates at low concentration, which is the case in hemangiomas, where SPIO particles are diluted in the blood pool and are not clustered.
The aim of this study was to evaluate whether SPIO particles could distinguish hemangiomas from other focal liver lesions, with a focus on the specificity of the T1 effect of SPIO particles, and thus to confirm findings previously published in a pilot study [17] .
Materials and methods
This study was performed after acceptance by the ethics committee of our institution. Forty-six patients with 83 focal liver lesions were studied with SPIO-enhanced MRI. Patients were referred for MRI examination to our institution for characterization of focal liver nodules seen on US and/or CT in patients without previous history of cancer (n ϭ 30), assessment of liver metastases (n ϭ 7), or HCC (n ϭ 9). All the consecutive examinations seen in MRI for liver lesion characterization were retrospectively retrieved by using the Radiology Information System of our department and the American College of Radiology coding system.
Standards of references ("gold standards")
Based on the clinical files, including reports from the surgical and the pathologic departments and radiologic examinations other than MRI, the cases were categorized as hemangiomas, FNHs, metastases, or HCCs.
The following criteria, ordered according to decreasing weighting, were used for the classification of the lesions, as indicated in Table 1 : surgical (or autopsy) and histologic findings, percutaneous biopsy and histologic findings, typical CT findings for hemangiomas and FNHs, clinical follow-up for hemangiomas, FNHs, metastases, and HCCs.
The CT studies were independently analyzed by three radiologists who did not participate in the reading of the MRI examinations. CT findings were considered as typical, if all three radiologists reported them as such, according to the following criteria.
1. Hemangiomas: strong globular peripheral enhancement, isodense with the aortic blood, during the hepatic arterial well-defined (lobulated) lesion in the arterial phase with a hypodense central scar, followed by a rapid washout during the portal phase, so that the lesion was iso-or slightly hyperdense relative to normal liver; isodensity relative to normal liver and hyperattenuating central scar [5] during the delayed phase (the acquisition of the latter phase was not mandatory).
The clinical follow-up as criterion for lesion characterization was evaluated in the following way. 
MRI examinations
These examinations were done on a 1.5-T Eclipse system (Marconi Medical Systems, Cleveland, OH, USA). The following imaging sequences were used:
1. Spin echo (SE) T1-weighted (repetition time [TR] ϭ 480 ms, echo time [TE] ϭ 8 ms, field of view ϭ 35-40 cm, matrix ϭ 256 ϫ 256, section thickness ϭ 10 mm, one signal acquired). We used an SE T1-weighted sequence instead of a field echo sequence to minimize the T2* effect. 2. Fast SE (FSE) T2-weighted (TR ϭ 4660 ms, TE ϭ 112 ms, echo train length ϭ 8, field of view ϭ 35-40 cm, matrix ϭ 512 ϫ 512, section thickness ϭ 10 mm, one or two signals acquired). The choice of a TE of 112 ms was dictated by a compromise between a long TE value for lesion characterization and an acceptable signal-to-noise ratio.
The same sequences were obtained before and after injection of SPIO particles (Ferumoxides, Endorem, Guerbet, Aulnay-sous-Bois, France) at a dose of 15 mol Fe/kg body weight. For the administration of SPIO particles, the patients were taken out of the MRI unit. The contrast agent was perfused slowly over 30 min. The patients were then asked to return into the magnet for the second part of the examination. Care were taken to place the patients in the same position by using the laser device of the MR unit. The postcontrast sequences were acquired between 1 and 1.5 h postinjection of SPIO particles.
Image analysis
The MR images were reviewed in conference by two radiologist (F.T., X.M.) who established a diagnosis in consensus. They were blinded to clinical information at the time of review. The number, localization, and morphologic aspect of the lesions were noted, especially whether they were hypo-, iso-, or hyperintense relative to liver parenchyma. In addition, the signal intensity ratio of the lesion was calculated. The ratio refers to the intensity of the lesions divided by the signal intensity of the paraspinal musculature. Data are presented as mean Ϯ standard deviation.
We applied Student's t tests to all our results, with p Ͻ 0.05 considered statistically significance.
At the end of the study, using the signal intensity ratio on the precontrast T2-weighted and postcontrast T1-weighted sequences of all 83 lesions, we constructed receiver operating characteristic (ROC) curves. On the curves, we determined the point nearest to the upper right corner, corresponding to the best sensitivity and specificity couple of the test. We also calculated the area under the curve (AUC) and compared the curves of the precontrast T2-weighted and postcontrast T1-weighted sequences. Thus we could evaluate the use of SPIO-enhanced T1-weighted sequence with the nonenhanced T2-weighted sequence. The latter is the traditional method for characterizing hemangiomas with MRI.
Results
The patients were grouped into the following categories, according to the criteria defined under Standards of Reference ("Gold Standards") ( Table 1) female ratio was seven to 13. The mean size of the hemangiomas was 19.8 (Ϯ 12.4) mm, with a range between 4 and 64 mm. The diagnosis was confirmed by surgical biopsies (n ϭ 1, giant hemangioma with Kasabach-Merritt syndrome), typical CT findings (n ϭ 13), or clinical follow-up (n ϭ 6; Table 1 ).
Focal nodular hyperplasias
Nine FNHs were found in eight patients. Patients' mean age was 40 years (Ϯ 12). The male-to-female ratio was two to six. The mean size of the FNHs was 33 mm (Ϯ 12), with a range between 12 and 54 mm. The diagnosis was confirmed by surgical biopsy (n ϭ 4), percutaneous biopsy (n ϭ 4), or clinical follow-up (n ϭ 1; Table 1 ).
Metastases
Eighteen metastases were found in eight patients. Patients' mean age was 55 years (Ϯ 15). The male-to-female ratio was six to two. The mean size of the metastases was 25 mm (Ϯ 15), with a range between 11 and 68 mm. The diagnosis was confirmed by surgical biopsy (n ϭ 4), percutaneous biopsy (n ϭ 3), or clinical follow-up (n ϭ 1; Table 1 ).
Hepatocellular carcinomas
Nineteen HCCs were found in 10 patients. Patients' mean age was 63 years (Ϯ 11). The male-to-female ratio was eight to two. The mean size of the HCCs was 23 mm (Ϯ 13), with a range between 7 and 49 mm. The diagnosis was confirmed by surgical biopsies (n ϭ 2), percutaneous biopsy (n ϭ 3), or autopsy (n ϭ 4).
Quantitative analysis
The results of the quantitative analysis are summarized in Table 2 .
Hemangiomas
On precontrast T1-weighted SE images, the hemangiomas appeared hypointense (Fig. 1 ) and sharply delineated, with a signal-to-noise ratio of 1.13 (Ϯ 0.34). On postcontrast T1-weighted SE images, hemangiomas became hyperintense, with a mean signal ratio of 1.92 (Ϯ 0.66). Thus, the signal ratio showed an increase of 70% on average after SPIO, which was statistically highly significant (p Ͻ 0.001). On T2-weighted FSE images, the hemangiomas were hyperintense on pre-and postcontrast images. Mean signal ratios on pre-and postcontrast images were 5.35 (Ϯ 3.77) and 3.56 (Ϯ 2.02), respectively. Thus, on postcontrast T2-weighted images, hemangiomas showed a significant signal drop of 50% (p ϭ 0.002).
Focal nodular hyperplasias
On precontrast T1-weighted SE images (Fig. 1) , the FNHs were almost isointense to the liver. The mean signal ratio was 1.50 (Ϯ 0.28). On postcontrast images, the FNHs remained almost isointense to the liver, and the mean signal ratio was 1.62 (Ϯ 0.40). This corresponded to an increase of 8% (p not significant).
On T2-weighted FSE images, the FNHs appeared hyperintense on pre-and postcontrast images. Mean signal ratios were 2.96 (Ϯ 0.45) and 1.88 (Ϯ 0.72) on T2-weighted preand postcontrast images, respectively. This represented a postcontrast signal drop of 36% (p ϭ 0.002).
Metastases
On precontrast T1-weighted SE images, the metastases appeared hypointense or isointense, with a mean signal ratio of 1.71 (Ϯ 0.79). On postcontrast T1-weighted SE images, the mean signal ratio was 1.58 (Ϯ 0.74), which was not significantly different from the signal ratio on the precontrast image.
On T2-weighted FSE images, the metastases were hyperintense on pre-and postcontrast images. The mean signal ratios were 3.14 (Ϯ 1.85) and 3.18 (Ϯ 2.40) on pre-and postcontrast images, respectively, with no significant difference.
Hepatocellular carcinomas
On precontrast T1-weighted SE images, the HCCs appeared isointense or slightly hyperintense, with a mean signal ratio of 1.99 (Ϯ 0.49). On postcontrast images, they appeared hyperintense, with a mean signal ratio of 1.92 (Ϯ 0.35). This represented a nonsignificant signal drop of 3%.
On T2-weighted FSE images, the HCCs appeared hyperintense before and after administration of SPIO. The mean signal ratios were 2.46 (Ϯ 0.57) and 3.49 (Ϯ 1.47) before and after contrast agent, respectively. This increase (42%) was nonsignificant.
Based on the ROC curves, a 100% specificity for the diagnosis of hemangioma on T1-weighted postcontrast im- Fig. 2 . ROC analysis based on pre-and postcontrast SE T1-weighted images. With a cutoff level of 50% signal increase, the specificity and sensitivity are 100% and 70%, respectively. The ROC analysis based on the T2-weighted sequence shows a smaller AUC than that of the T1-weighted sequence.
ages was obtained by using a cutoff value of a 50% signal intensity ratio increase. The corresponding sensitivity was 70% (Fig. 2) .
A 100% specificity for the diagnosis of hemangioma on T2-weighted images was obtained by using a cutoff value of 10% of signal intensity ratio. The corresponding sensitivity was 17%.
The AUC calculated from the T1-weighted sequence (0.95) was superior to the AUC calculated from the T2-weighted sequence (0.86). Moreover, for each cutoff value, the sensibility and specificity of the postcontrast T1-weighted sequence were superior to those of the T2-weighted sequence.
Discussion
Hepatic hemangiomas have a prevalence between 3% and 5% in the general population, according to the literature [5, 9, 22] . Most hemangiomas are small, solitary, asymptomatic lesions that are discovered incidentally during imaging performed for other clinical indications. Our collective of patients had 40% multiple hemangiomas, which is above the reported rate [8] . This result is likely due to the fact that, in the current study, the patients who underwent MRI had lesions not adequately characterized by other imaging studies, especially CT. The presence of multiple lesions is typically such a situation.
It is generally accepted that patients with a known extrahepatic malignancy or patients at high risk for HCC should undergo imaging in addition to US to confirm or reject the diagnosis of hemangioma [20] . Commonly, this additional imaging procedure will entail enhanced CT or MRI, with the latter including T2-weighted images and a postgadolinium dynamic T1-weighted sequence. In a certain number of cases, these two methods do not allow a definite diagnosis [23, 24] .
Several investigators have considered that the very high signal intensity of hemangiomas on T2-weighted images is sufficient for an accurate diagnosis, especially if a long TE in the range of 180 -200 ms, is used. Such long TEs are known to improve characterization of liver hemangiomas [25] [26] [27] . In our study, in which moderately T2-weighted sequences (TE ϭ 112 ms) were used, the intensity of hemangiomas was on average higher than that of other focal liver lesions, but with an important overlap of signal intensity between hemangiomas and other focal lesions (Fig. 3) . From the literature, it is well known that, on the one hand, liver hemangiomas can have only moderate hypersignal on T2-weighted sequences. On the other hand, some metastases can be hyperintense on T2-weighted images [28] . Thus, intensity values on T2-weighted images lack specificity for differentiating hemangiomas from other focal liver lesions, especially if only a moderately T2-weighted sequence is used There is an important overlap between signal intensities of these lesions. Note the decreased signal intensity of hemangiomas postinjection of SPIO particles, thereby increasing the overlap in signal intensity with metastases and HCCs, which explains why the differential diagnosis between hemangiomas and malignant tumors is even more difficult, if only postcontrast images are obtained. [29] . Even if morphologic criteria are included, atypical hemangiomas are still difficult to characterize [28, 30] .
Moreover, dynamic CT or MRI can be inconclusive, especially in cases of very small or very large hemangiomas. Thus, there is a need for a more specific method to establish a clear-cut diagnosis of liver hemangiomas and avoid biopsies or even surgical exploration.
We expected that SPIO particles, which do not have the same type of behavior as iodinated contrast agent on CT, would provide additional information for the diagnosis of liver hemangiomas. When we started the current study, our MR unit did not have the technical requirements to cover the liver completely with a T1-weighted sequence during the hepatic arterial phase. We hypothesized that the use of SPIO particles in association with an SE T1-weighted sequence, thus obviating a rapid image acquisition, could increase our confidence for the diagnosis of liver hemangiomas as compared with a T2-weighted sequence alone. Our results confirmed our expectation.
The T2 effect of SPIO particles is well known [10, [31] [32] [33] [34] [35] . Because these particles decrease liver signal intensity on T2-weighted sequences and cause no signal change in lesions that lack Kupffer cells, they increase the lesion-toliver contrast and improve lesion detection. Metastases and HCCs usually do not take up SPIO particles because they lack Kupffer cells [16, 36, 37] , although well-differentiated HCCs may contain Kupffer cells [38] . SPIO particles also have a potent r1 relaxivity, with a value of 23.7 mmol/s at 39.5°C and 20 MHz for ferumoxides. Therefore, even if the r2 relaxivity is higher than the r1 relaxivity (107 mmol/s in the same conditions), we can expect a nonnegligible T1 effect of ferumoxides. This effect is dose dependent and is observed at low concentrations [39] . In vivo, such an effect has been reported in hemangiomas on T1-weighted SE sequences [17] and has been confirmed in the present study by showing a high specificity for the diagnosis of liver hemangiomas. The T1 effect of SPIO particles is likely time dependent. Immediately after administration, large clusters of particles are circulating, thereby inducing a substantial T2 effect. Within minutes, the larger particles are preferentially sequestered by the reticulo-endothelial system, whereas the smaller ones, responsible for the T1 effect, remain in circulation. However, in our study, we did not evaluate this time dependency because the contrast medium was slowly perfused, and only late images were acquired (1-1.5 h postinjection of SPIO particles).
Hemangiomas are the only lesions that have statistically significant enhancement on SE T1-weighted sequences postinjection of SPIO particles. This increase was on average 70% in our study. A major advantage of using SPIO-enhanced MRI for characterizing hemangiomas is that even atypical hemangiomas on CT can showed enhancement on T1-weighted SE images (Figs. 4 -7) . In addition, the ROC analysis showed that the optimized sensitivity and specificity couple is obtained when using a cutoff level of 50% signal increase. With this cutoff value, the specificity and sensitivity are 100% and 70%, respectively. We focused on a test with excellent specificity to avoid unnecessary biopsies or surgical interventions. Moreover, the AUC of the T1-weighted sequence was higher than that of the native T2-weighted sequence, indicating a better accuracy of the SPIOenhanced T1-weighted sequence, at least for the TE value we used. The use of a more heavily T2-weighted sequence might have produced better results, but, as previously mentioned, we choose a TE of 112 ms as a compromise to obtain an acceptable signal-to-noise ratio. In our opinion, positive enhancement on a T1-weighted sequence postinjection of SPIO particles is complementary to high signal intensity of hemangiomas on T2-weighted sequences for establishing an accurate diagnosis.
A major drawback of using SPIO particles is that the procedure is lengthy, if one performs pre-and postcontrast imaging. Nevertheless, we strongly believe that precontrast images are also required for accurate lesion characterization because they are needed to calculate the signal enhancement of a lesion. Visual evaluation or even measurement of lesionto-liver contrast on post-SPIO particles T1-weighted images alone is not sufficient. It is necessary to measure the signal increase between pre-and postcontrast images: an enhancement greater than 50% is characteristic of hemangiomas. On T2-weighted sequences, signal intensity of hemangiomas is decreased postinjection of SPIO [40] (Fig. 3) , thus making the differential diagnosis between hemangiomas and malignant lesion more difficult than on precontrast images.
In our institution, we now use SPIO particles routinely for the definitive characterization of liver hemangiomas when CT is inconclusive. Because of potential cardiac side effects and low back pain, ferumoxides cannot be injected as a bolus; therefore, a dynamic sequence cannot be performed. The advent of a new generation of SPIO particles (Resovist, Schering, Germany), which can be injected as a bolus, has removed this major limitation. Dynamic sequences can now be acquired that combines the advantages of imaging in the vascular phase and the phase of uptake by the reticuloendothelial system for improved detection and characterization of focal liver lesions. Nevertheless, to our knowledge, there has been no study validating the usefulness of dynamic images using SPIO particles. The much shorter duration of the MR examination with Resovist is the most obvious advantage over Endorem. Fig. 7 . Small hemangioma in a cirrhotic liver. CT scans of a small lesion in native (A), arterial hepatic phase (B), and portal venous phase (C) show a hypervascular tumor without rapid washout. Corresponding T1-weighted sequence before (D) and after (E) SPIO and T2-weighted images before (F) and after (G) SPIO. Note the enhancement of the lesion post-SPIO injection on the T1-weighted sequence. This lesion was diagnosed as hemangioma and confirmed by histology after liver transplantation.
In conclusion, when SPIO particles are used as a contrast agent for liver imaging, the addition of a T1-weighted sequence is useful because it helps to characterize hemangiomas and to differentiate them from other solid liver lesions.
